4//SEC Filing
ZELINGER JOSEF 4
Accession 0001493152-23-029950
CIK 0001517681other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:05 PM ET
Size
8.0 KB
Accession
0001493152-23-029950
Insider Transaction Report
Form 4
ZELINGER JOSEF
Director
Transactions
- Award
Common Stock Purchase Warrant
2023-07-05+15,000,000→ 15,000,000 total(indirect: By Aggro Investments Pty Ltd)Exercise: $0.01From: 2023-07-05Exp: 2026-07-05→ Common Stock (15,000,000 underlying)
Holdings
- 2,805
Common Stock
Footnotes (4)
- [F1]On May 1, 2023, the issuer effected a 1-for-1,000 reverse stock split (the "Reverse Split") of its outstanding shares of common stock, par value $0.001 per share ("Common Stock"). The number of shares of Common Stock reported on this Form 4 has been adjusted to reflect the Reverse Split as it pertained to the number of shares of Common Stock that the reporting person held immediately following the Reverse Split.
- [F2]The reporting person's Form 3 filed on August 20, 2021 inadvertently failed to report an additional 5 shares of Common Stock directly owned in error. Due to the method of rounding fractional shares of Common Stock held by the reporting person after the Reverse Split, the number of shares of Common Stock reported on this Form 4 has also been adjusted to correct the reporting person's total ownership as of August 23, 2023.
- [F3]Due to an administrative error, the reporting person inadvertently failed to report the beneficial ownership of the common stock purchase warrant (the "Warrant") issued to Aggro Investments Pty Ltd ("Aggro Investments") on July 5, 2023. The Warrant is currently exercisable, with shares of Common Stock issuable upon exercise subject to a 4.99% blocker based upon the aggregate number of shares of Common Stock outstanding on the date of such exercise. The reporting person wholly owns and controls Aggro Investments, but disclaims beneficial ownership of the Warrant and shares issuable pursuant to its exercise, except to the extent of the reporting person's pecuniary interest therein.
- [F4]Reflects the receipt of the Warrant for no additional consideration in connection with a loan from Aggro Investments to the issuer on July 5, 2023.
Documents
Issuer
Propanc Biopharma, Inc.
CIK 0001517681
Entity typeother
Related Parties
1- filerCIK 0001876019
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 4:05 PM ET
- Size
- 8.0 KB